eburnamonine has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woods, JR | 1 |
| Riofski, MV | 1 |
| Zheng, MM | 1 |
| O'Banion, MA | 1 |
| Mo, H | 1 |
| Kirshner, J | 1 |
| Colby, DA | 1 |
| Komoto, C | 1 |
| Nakamura, T | 1 |
| Yamamori, M | 1 |
| Ohmoto, N | 1 |
| Kobayashi, H | 1 |
| Kuwahara, A | 1 |
| Nishiguchi, K | 1 |
| Takara, K | 1 |
| Tanigawara, Y | 1 |
| Okamura, N | 1 |
| Okumura, K | 1 |
| Sakaeda, T | 1 |
2 other studies available for eburnamonine and Benign Neoplasms
| Article | Year |
|---|---|
Synthesis of 15-methylene-eburnamonine from (+)-vincamine, evaluation of anticancer activity, and investigation of mechanism of action by quantitative NMR.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; | 2013 |
Reversal effects of Ca2+ antagonists on multidrug resistance via down-regulation of MDR1 mRNA.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transport | 2008 |